Campbell & Co. Investment Adviser »

Silverback Therapeutics shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in Silverback Therapeutics

23:59:59.999Sep 29, 202423:59:59.999500:00:00Sep 30, 202400:00:00.000500:00:00.001310.966k310.9665k310.967k310.9675k310.968k21.445k21.4455k21.446k21.4465k21.447k
Value ($)Share countHistorical SPRY position of Campbell & Co. … Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2024-09-30 $311k 21k 14.50

More positions owned by Campbell & Co. Investment Adviser

Intercontinental Exchange In Common Stock (ICE)
Fastenal Common Stock (FAST)
Novartis Adr (NVS)
Hca Healthcare Common Stock (HCA)
Schwab Charles Corp Common Stock (SCHW)
Electronic Arts Common Stock (EA)
Elevance Health Common Stock (ELV)
Grainger W W Common Stock (GWW)
Packaging Corp Amer Common Stock (PKG)
Roper Technologies Common Stock (ROP)
Mondelez Intl Common Stock (MDLZ)
Aflac Common Stock (AFL)
Applied Matls Common Stock (AMAT)
Marketaxess Hldgs Common Stock (MKTX)
Ameriprise Finl Common Stock (AMP)

View all positions for Campbell & Co. Investment Adviser

Top funds holding Silverback Therapeutics

RA Capital Management
Deerfield Management Company
OrbiMed Advisors
BlackRock
Sr One Capital Management
Alliancebernstein
Vanguard Group
State Street Corporation
Franklin Resources
Alyeska Investment Group
Geode Capital Management
Woodline Partners
Nextech Invest
FMR
Citadel Advisors

View all funds holding Silverback Therapeutics